Skip to content

A Feasibility Open Trial of App-Enhanced Brief CBT for Suicidal Inpatients

A Feasibility Open Trial of App-Enhanced Brief CBT for Suicidal Inpatients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05486091
Enrollment
4
Registered
2022-08-03
Start date
2022-10-03
Completion date
2023-02-15
Last updated
2024-08-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Suicidal and Self-injurious Behavior

Brief summary

The purpose of this study is to evaluate the feasibility of integrating Brief Cognitive-Behavioral Therapy (BCBT) counseling with a software application (app) to prevent future suicidal thoughts and behaviors.

Detailed description

Participants will provide written informed consent. Participants will complete up to 4 sessions of BCBT (depending on length of stay) incorporating the use of a SmartPhone app. This study treatment will be completed in addition to usual care in an open trial design. Assessments will be completed at intake, discharge, and 1-, 2-, and 3-month follow-up.

Interventions

BEHAVIORALApp-Enhanced Brief Cognitive-Behavioral Therapy

BCBT is a cognitive-behavioral intervention designed to target core skills deficits among suicidal individuals. App-enhanced BCBT incorporates the use of a SmartPhone app during the therapy sessions.

Sponsors

Oui Therapeutics, Inc.
CollaboratorINDUSTRY
Hartford Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 24 Years
Healthy volunteers
No

Inclusion criteria

* History of suicide attempt (lifetime) AND active ideation (with or without plan or intent) on admission * Own and have access to their phone (iPhone or Android with capability to download apps) during their inpatient stay * Ability to understand the nature of the study and provide written informed consent * Willing and able to provide at least two verifiable contacts for emergency or tracking purposes * Expected length of stay long enough to complete the entire treatment protocol

Exclusion criteria

* Not fluent in English * Experiencing current mania or psychosis * Have lifetime history of schizophrenia spectrum disorder, intellectual disability, or organic brain illness * Inpatient treatment plan includes detox protocol or electroconvulsive therapy * Any other psychiatric or medical condition that in the investigator's opinion would preclude informed consent or participation in the trial

Design outcomes

Primary

MeasureTime frameDescription
Client Satisfaction at DischargeAssessed at completion of inpatient treatment (average of 16 days from admission)The Client Satisfaction Questionnaire (CSQ) contains 8 multiple choice items and assesses the acceptability and satisfaction of the study treatment. Items are rated from 1 to 4. Items are added together for a total score ranging from 8 to 32 with higher numbers representing greater satisfaction with the treatment. The mean and standard deviation for the CSQ total score will be reported utilizing all available data.
App Usability at DischargeAssessed at completion of inpatient treatment (average of 16 days from admission)The System Usability Scale (SUS) contains 10 items assessing the usability of digital technology. Items are rated from 1 to 5, with higher numbers representing stronger agreement with usability statements. Scores can range from 0 to 100, with higher scores reflecting better outcomes, meaning increased usability of the technology. The mean and standard deviation for the SUS will be reported utilizing all available data.
Frequency of Suicide Attempts3 months post-discharge from inpatient unitFrequency (percentage) of participants who made a suicide attempt over the entire follow-up period
Suicidal Ideation 2 Months2 months after dischargeThe Adult Suicidal Ideation Questionnaire (ASIQ) assesses the frequency of suicidal ideation. The ASIQ contains 25 items rated on a 0-6 scale. Items are added together for a total score ranging from 0 to 150. Higher scores indicate more frequent suicidal ideation. Means and standard deviations of the total score will be reported utilizing all available data.
Suicidal Ideation BaselineBaseline (before receiving BCBT intervention)The Adult Suicidal Ideation Questionnaire (ASIQ) assesses the frequency of suicidal ideation. The ASIQ contains 25 items rated on a 0-6 scale. Items are added together for a total score ranging from 0 to 150. Higher scores indicate more frequent suicidal ideation. Means and standard deviations of the total score will be reported utilizing all available data.
Suicidal Ideation at DischargeAssessed at completion of inpatient treatment (average of 16 days from admission)The Adult Suicidal Ideation Questionnaire (ASIQ) assesses the frequency of suicidal ideation. The ASIQ contains 25 items rated on a 0-6 scale. Items are added together for a total score ranging from 0 to 150. Higher scores indicate more frequent suicidal ideation. Means and standard deviations of the total score will be reported utilizing all available data.
Suicidal Ideation 1 Month1 month after dischargeThe Adult Suicidal Ideation Questionnaire (ASIQ) assesses the frequency of suicidal ideation. The ASIQ contains 25 items rated on a 0-6 scale. Items are added together for a total score ranging from 0 to 150. Higher scores indicate more frequent suicidal ideation. Means and standard deviations of the total score will be reported utilizing all available data.
Suicidal Ideation 3 Months3 months after dischargeThe Adult Suicidal Ideation Questionnaire (ASIQ) assesses the frequency of suicidal ideation. The ASIQ contains 25 items rated on a 0-6 scale. Items are added together for a total score ranging from 0 to 150. Higher scores indicate more frequent suicidal ideation. Means and standard deviations of the total score will be reported utilizing all available data.

Countries

United States

Participant flow

Participants by arm

ArmCount
App-Enhanced Brief Cognitive-Behavioral Therapy
Up to 4 in-person sessions App-Enhanced Brief Cognitive-Behavioral Therapy: BCBT is a cognitive-behavioral intervention designed to target core skills deficits among suicidal individuals. App-enhanced BCBT incorporates the use of a SmartPhone app during the therapy sessions.
4
Total4

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyLost to Follow-up2
Overall StudyWithdrawal by Subject1

Baseline characteristics

CharacteristicApp-Enhanced Brief Cognitive-Behavioral Therapy
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
4 Participants
Age, Continuous22.00 years
STANDARD_DEVIATION 2.83
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
3 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
2 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
2 Participants
Sex: Female, Male
Female
0 Participants
Sex: Female, Male
Male
4 Participants
Suicidal Ideation Baseline82.00 score on a scale
STANDARD_DEVIATION 58.09

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 4
other
Total, other adverse events
1 / 4
serious
Total, serious adverse events
0 / 4

Outcome results

Primary

App Usability at Discharge

The System Usability Scale (SUS) contains 10 items assessing the usability of digital technology. Items are rated from 1 to 5, with higher numbers representing stronger agreement with usability statements. Scores can range from 0 to 100, with higher scores reflecting better outcomes, meaning increased usability of the technology. The mean and standard deviation for the SUS will be reported utilizing all available data.

Time frame: Assessed at completion of inpatient treatment (average of 16 days from admission)

ArmMeasureValue (MEAN)Dispersion
App-Enhanced Brief Cognitive-Behavioral TherapyApp Usability at Discharge95.00 score on a scaleStandard Deviation 4.33
Primary

Client Satisfaction at Discharge

The Client Satisfaction Questionnaire (CSQ) contains 8 multiple choice items and assesses the acceptability and satisfaction of the study treatment. Items are rated from 1 to 4. Items are added together for a total score ranging from 8 to 32 with higher numbers representing greater satisfaction with the treatment. The mean and standard deviation for the CSQ total score will be reported utilizing all available data.

Time frame: Assessed at completion of inpatient treatment (average of 16 days from admission)

ArmMeasureValue (MEAN)Dispersion
App-Enhanced Brief Cognitive-Behavioral TherapyClient Satisfaction at Discharge29.00 score on a scaleStandard Deviation 3.61
Primary

Frequency of Suicide Attempts

Frequency (percentage) of participants who made a suicide attempt over the entire follow-up period

Time frame: 3 months post-discharge from inpatient unit

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
App-Enhanced Brief Cognitive-Behavioral TherapyFrequency of Suicide Attempts0 Participants
Primary

Suicidal Ideation 1 Month

The Adult Suicidal Ideation Questionnaire (ASIQ) assesses the frequency of suicidal ideation. The ASIQ contains 25 items rated on a 0-6 scale. Items are added together for a total score ranging from 0 to 150. Higher scores indicate more frequent suicidal ideation. Means and standard deviations of the total score will be reported utilizing all available data.

Time frame: 1 month after discharge

ArmMeasureValue (MEAN)Dispersion
App-Enhanced Brief Cognitive-Behavioral TherapySuicidal Ideation 1 Month21.00 score on a scaleStandard Deviation 7.21
Primary

Suicidal Ideation 2 Months

The Adult Suicidal Ideation Questionnaire (ASIQ) assesses the frequency of suicidal ideation. The ASIQ contains 25 items rated on a 0-6 scale. Items are added together for a total score ranging from 0 to 150. Higher scores indicate more frequent suicidal ideation. Means and standard deviations of the total score will be reported utilizing all available data.

Time frame: 2 months after discharge

ArmMeasureValue (MEAN)Dispersion
App-Enhanced Brief Cognitive-Behavioral TherapySuicidal Ideation 2 Months25.00 score on a scaleStandard Deviation 0
Primary

Suicidal Ideation 3 Months

The Adult Suicidal Ideation Questionnaire (ASIQ) assesses the frequency of suicidal ideation. The ASIQ contains 25 items rated on a 0-6 scale. Items are added together for a total score ranging from 0 to 150. Higher scores indicate more frequent suicidal ideation. Means and standard deviations of the total score will be reported utilizing all available data.

Time frame: 3 months after discharge

ArmMeasureValue (MEAN)Dispersion
App-Enhanced Brief Cognitive-Behavioral TherapySuicidal Ideation 3 Months45.00 score on a scaleStandard Error 0
Primary

Suicidal Ideation at Discharge

The Adult Suicidal Ideation Questionnaire (ASIQ) assesses the frequency of suicidal ideation. The ASIQ contains 25 items rated on a 0-6 scale. Items are added together for a total score ranging from 0 to 150. Higher scores indicate more frequent suicidal ideation. Means and standard deviations of the total score will be reported utilizing all available data.

Time frame: Assessed at completion of inpatient treatment (average of 16 days from admission)

ArmMeasureValue (MEAN)Dispersion
App-Enhanced Brief Cognitive-Behavioral TherapySuicidal Ideation at Discharge46.67 score on a scaleStandard Deviation 19.14
Primary

Suicidal Ideation Baseline

The Adult Suicidal Ideation Questionnaire (ASIQ) assesses the frequency of suicidal ideation. The ASIQ contains 25 items rated on a 0-6 scale. Items are added together for a total score ranging from 0 to 150. Higher scores indicate more frequent suicidal ideation. Means and standard deviations of the total score will be reported utilizing all available data.

Time frame: Baseline (before receiving BCBT intervention)

ArmMeasureValue (MEAN)Dispersion
App-Enhanced Brief Cognitive-Behavioral TherapySuicidal Ideation Baseline82.00 score on a scaleStandard Deviation 58.09

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026